- Home
- /
- Treatment
- /
- Page 83
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Vocimagene amiretrorepvec and flucytosine | Glioblastoma | Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109 | January 12, 2011 | |
N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino] isonicotinamide hydrochloride | Acute myeloid leukemia | EMD Serono, Inc.;1 Technology Place;Rockland, Massachusetts, 02370 | January 12, 2011 | |
Anti-TCR murine monoclonal antibody (MAB, type IgM) | Pediatric multiple sclerosis | Tolera Therapeutics, Inc.;350 E. Michigan Ave.;Kalamazoo, Michigan, 49008 | January 12, 2011 | |
[AC3-yCD2(V)] and Flucytosine (5-FC XR) | Glioblastoma multiforme | Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109 | January 12, 2011 | |
Dabrafenib | Metastatic Melanoma | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936 | January 12, 2011 | |
Vocimagene amiretrorepvec and flucytosine | Glioblastoma multiforme | Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109 | January 12, 2011 | |
4-[131I]iodo-L-phenylalanine | Glioma | Therapeia GmbH & Co KG;Veilchenweg 38, D-01326 Dresden; | January 4, 2011 | |
Bortezomib | Follicular lymphoma | Millennium Pharmaceuticals, Inc.;40 Landsdowne Street;Cambridge, Massachusetts, 02139 | January 4, 2011 | |
GVAX melanoma | Metastatic Melanoma | Aduro BioTech, Inc.;740 Heinz Avenue;Berkeley, California, 94710 | December 23, 2010 | |
Calcium benzoate and risperidone | Pediatric patients with schizophrenia | University of California, Los Angeles;Dept. of Psychiarty, HH212, 1000 W. Carson Street;Torrance, California, 90509 | December 20, 2010 | |
Ex-vivo expanded autologous bone marrow-derived mesenchymal stem cells | Amyotrophic lateral sclerosis | TCA Cellular Therapy, LLC;101 Judge Tanner Blvd.;Covington, Louisiana, 70433 | December 20, 2010 | |
Crenolanib | Malignant glioma | AROG Pharmaceuticals, LLC;12400 Coit Road, Suite 570;Dallas, TX, 75251 | December 20, 2010 | |
Crenolanib besylate | Glioma | AROG Pharmaceuticals, LLC;Two Lincoln Centre, Suite 410;Dallas, Texas, 75240 | December 20, 2010 | |
Denosumab | Patients with giant cell tumor of bone | Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California, 91320 | December 20, 2010 | |
Dinutuximab | Neuroblastoma | United Therapeutics Corporation;55 TW Alexander Drive;Research Triangle Park, North Carolina, 27709 | December 20, 2010 | |
NDX-peptides | Amyotrophic lateral sclerosis | NeoDiagnostic Research Ltd;Sheraton House 1st Floor, Chorleywood;Herts WD3 5LH | December 14, 2010 | |
DNA plasmid vector expressing eIF5Ak50 | Multiple myeloma | Senesco Technologies, Inc.;303 George Street;New Brunswick, New Jersey, 08901 | December 13, 2010 | |
Fidaxomicin | Pediatric Clostridium difficile infection | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc.;20 Weystrasse;Luzern | December 13, 2010 | |
Dermagraft | Dystrophic epidermolysis bullosa | Shire Regenerative Medicine, Inc.;11095 Torreyana Road, subsidiary of Shire Pharmaceuticals.;San Diego, California, 92121 | December 13, 2010 | |
Cediranib | Glioblastoma | National Institutes of Health;National Cancer Institute, 9609 Medical Center Dr.;Bethesda, Maryland, 20892 | December 13, 2010 | |
Acyclovir | Herpetic keratitis | Fera Pharmaceuticals;134 Birch Hill Road;Locust Valley, New York, 11560 | December 13, 2010 | |
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl acetate 9-cis-retinyl acetate (API) | Leber congenital amaurosis | Novelion Therapeutics, Inc.;887 Great Northern Way - Suite 250, Vancouver, British Columbia;V5T 4T5 | December 2, 2010 | |
(2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate | Retinitis pigmentosa | Novelion Therapeutics, Inc.;887 Great Northern Way - Suite 250, Vancouver, British Columbia, V5T 4T5; | December 2, 2010 | |
Allogeneic cord blood cells, ex vivo modulated with 16,16 dimethyl prostaglandin E2 (dmPGE2) | Enhancement of stem cell engraftment through ex vivo treatment of human allogeneic hematopoietic stem cells (treatment of neuropenia, thrombocytopenia, lymphopenia, and anemia) | Fate Therapeutics, Inc.;3535 General Atomics Court;San Diego, California, 92121 | December 2, 2010 | |
(Z)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}guanine, cyclopropavir, ZSM-1-62 and NSC D745998 | Active cytomegalovirus infections | Microbiotix, Inc.;One Innovation Drive;Worcester, MA, 01605 | November 29, 2010 |